Colorectal cancer risk in relation to use of acid suppressive medications
Authors:
- 14 April 2009
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 18 (7) , 540-544
Abstract
Purpose Acid suppressants are commonly prescribed medications. Laboratory studies suggest a mechanism by which they could increase colorectal cancer (CRC) risk. A few epidemiologic studies have investigated acid suppressant use and CRC risk; none has documented an overall association. We sought to investigate whether acid suppressants are associated with CRC risk. Methods We conducted a case–control study among members of an integrated healthcare delivery system in Washington State. Cases (N = 641) were diagnosed with CRC between 2000 and 2003; controls (N = 641) were randomly selected from enrollees and matched to cases on age, sex, and length of enrollment. We used conditional logistic regression to estimate the odds ratios (ORs) and 95% confidence intervals (CI) for CRC associated with the use of any acid suppressive medication, proton pump inhibitors (PPIs) only, histamine receptor antagonists (H2 blockers) only, or both PPIs and H2 blockers in relation to the use of neither PPIs nor H2 blockers. Results Use of PPIs exclusively was modestly associated with an increased risk of CRC, however this finding was consistent with chance and based on a small number of patients exposed (OR = 1.7; 95%CI = 0.8, 4.0). H2 blocker use alone was not related to CRC risk (OR = 0.8; 95%CI = 0.6, 1.1). Conclusions PPI use may be modestly associated with CRC risk; further research should be conducted in populations with long‐term PPI use. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
Funding Information
- NCI (CA11085)
This publication has 28 references indexed in Scilit:
- Cardiovascular Medication Use and Risk for Colorectal CancerCancer Epidemiology, Biomarkers & Prevention, 2008
- Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: PointCancer Epidemiology, Biomarkers & Prevention, 2008
- Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: CounterpointCancer Epidemiology, Biomarkers & Prevention, 2008
- Statin use and prostate cancer risk in a large population-based settingCancer Causes & Control, 2008
- Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studiesThe Lancet, 2007
- Processing and proliferative effects of human progastrin in transgenic mice.Journal of Clinical Investigation, 1996
- Effect of Omeprazole-Induced Hypergastrinaemia on the Proliferation of Colonic Mucosal Epithelial Cells in the RatExperimental and Clinical Endocrinology & Diabetes, 1991
- Inhibition by tetragastrin of experimental carcinogenesis in rat colon: Effect of wheat bran consumptionInternational Journal of Cancer, 1988
- Hypergastrinemia and colorectal carcinogenesis in the ratCancer Letters, 1985
- Trophic Effects of Gastrin on Colorectal Neoplasms in the RatAnnals of Surgery, 1982